Skip to main content
Log in

Clinical study on treatment of mammary cancer by Shenqi Fuzheng Injection (参芪 扶正注射液) in cooperation with chemotherapy

  • Original Article
  • Published:
Chinese Journal of Integrative Medicine Aims and scope Submit manuscript

Abstract

Objective

To study the effect of Shenqi Fuzheng Injection (参芪 扶正注射液, SFI) on cellular immune in patients with mammary cancer (MC) after chemotherapy.

Methods

One hundred and ten patients with MC were randomly assigned to two groups. The 58 patients in the tested group were treated with SFI in cooperation with chemotherapy of CAF protocol (Cyclophosphamide, Doxorubicin and Fluorouracil), while the 52 patients in the control group were treated with chemotherapy of the same protocol alone. Changes of the patients’ quality of life (QOF), adverse reaction that occurred, peripheral lymphocyte count and killing activity of single karyocyte before and after treatment between the two groups were compared.

Results

Patients’ QOF elevating rate after treatment in the tested group and the control group was 34.5% and 13.5% respectively; The lowering of peripheral blood cell count of WBC, platelet and lymphocyte as well as that of the killing activity of single peripheral karyocyte on various kinds of MC cells were all milder and recovery sooner than those in the control group.

Conclusion

SFI in combination with chemotherapy in treating MC could reduce the occurrence of adverse reaction to chemotherapy, improve clinical symptoms, elevate QOF and enhance immunity in patients with MC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Chai KQ, Ying XH. Exploration on the mechanism of vital energy supporting principle in regulating immunity. J Zhejiang Tradit Chin Med Coll 2003; 27(4): 14–15.

    Google Scholar 

  2. Ohtake N, Suzuki R, Daikuhara H, et al. Modulation of lung local immune responses by oral administration of a herbal medicine Sho-saiko-to. Int J Immunopharmacol 2000;22:419–430.

    Article  PubMed  CAS  Google Scholar 

  3. Zhou WS, Liu ZD, Wu LS. Diagnostic and treatment principles of combined traditional Chinese medicine with Western medicine for hepatocellular carcinoma. Bull Chin Cancer 2003; 12(9): 512–514.

    Google Scholar 

  4. Bussiere M, Hopman W, Day A, et al. Indicators of functional status for primary malignant brain tumour patients. Can J Neurol Sci 2005; 32: 50–56.

    PubMed  Google Scholar 

  5. Yu SZ, Yang GH, Feng JM. Clinical study on treatment of malignant neoplasms with Shenqi Fuzheng Injection and chemotherapy. J Chin Integr Med 2006; 4(1): 84–86.

    Google Scholar 

  6. Wang N, Huang LP. Effect of Shen Qi Fu Zheng Injection on lymphatic cells. Chin J Surg Integr Tradit West Med 2006; 12(2): 139–142.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yang Bo  (杨波).

Additional information

Supported by Integrative Medicine Foundation of State Administration of Guangdong Province (No.1050068), Traditional Chinese Medicine Foundation and Integrative Medicine Foundation of Guangzhou City (No.2005A038)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yang, B., Li, Hs., Qi, Yc. et al. Clinical study on treatment of mammary cancer by Shenqi Fuzheng Injection (参芪 扶正注射液) in cooperation with chemotherapy. Chin. J Integ. Med. 13, 37–40 (2007). https://doi.org/10.1007/s11655-007-0037-5

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11655-007-0037-5

Key words

Navigation